This wiki has undergone a migration to Confluence found Here
Difference between revisions of "January 2018 WGM New Orleans; Jan 27 to Feb 8"
Jump to navigation
Jump to search
(→Agenda) |
(→Agenda) |
||
Line 229: | Line 229: | ||
<td>40</td> | <td>40</td> | ||
<td> * Agenda: <br> * Negation <br> * harmonization across specification families <br> * other vocab topics | <td> * Agenda: <br> * Negation <br> * harmonization across specification families <br> * other vocab topics | ||
− | <br> * Meeting notes: </td> | + | <br> * Michael T to Pharmacy/BRR re medication knowledge <br> * Meeting notes: </td> |
<td>Patient Care</td> | <td>Patient Care</td> | ||
<td>Accepted: CIMI, Vocab, Clin Genomics, SD, OO</td> | <td>Accepted: CIMI, Vocab, Clin Genomics, SD, OO</td> |
Revision as of 22:40, 8 January 2018
- Back to Patient Care
- Back to 2018 PCWG WGM Agenda and Minutes
New Orleans WGM - Jan 2018 Patient Care WG Meeting Draft/Approved agenda:
NOTE- to view WGM meeting minutes: follow the link for each quarter in Event column of the agenda below
Agenda
Day | Time | Qtr | Room | # | Event | Host | Joining | Chair | Scribe |
---|---|---|---|---|---|---|---|---|---|
Sunday Jan 28 |
AM | Q1 | |||||||
Q2 | |||||||||
PM | Q3 | ||||||||
Q4 | |||||||||
Day | Time | Room | # | Event | Host | Joining | Chair | Scribe | |
Monday Jan 29 |
AM | Q1 | TBD | 20 | * Agenda: PCWG Admin * DMP review * PCWG Jan 2018 WGM Monday Q1 Meeting notes |
Patient Care | Michelle | who? | |
Q2 | TBD | 20 | Notes (e.g. SOAP Notes) Health Concern - tracking/linking heterogeneous resources * PCWG Jan 2018 WGM Monday Q2 Meeting notes |
Patient Care | Accepted: SD, FHIR-I,EC | Jay/Michael | who? | ||
Q2b | TBD | NA | Podiatry Functional Profile Head | EHR | NA | who? | |||
PM | Q3 | TBD | NA | * Agenda: Mega Report Out * Meeting notes - refer to EHRWG meeting minutes * PCWG presentation slide deck: insert here |
EHR | Accepted: Patient Care | NA | who? | |
Q4 | TBD | NA | * Agenda: Joint Session with FHIR & OO on FHIR workflow | FHIR-I | Accepted: PC | NA | who? | ||
Day | Time | Room | # | Event | Host | Joining | Chair | Scribe | |
Tuesday Jan 30 |
AM | Q1 | TBD | 40 | * Agenda: FHIR/PCWG - CIMI - Skin Care model meeting
* Meeting notes |
Patient Care | Accepted: CIMI, EC | Jay | Who? |
Q2 | TBD | 20 | * Agenda: FHIR Change requests * Meeting notes: |
Patient Care | Declined: FHIR-I | Michelle | Michelle | ||
PM | lunch | ? |
|||||||
Q3a | TBD | 20 | * Agenda: FHIR Admin and Change requests *Meeting notes: |
Patient Care | Accepted: FHIR-I | Michelle | Michelle | ||
Q3b | TBD | NA | * Agenda: SD Hosted Joint Quarter: CDA Product Family * Meeting notes: |
SD | NA | who? | |||
Q4 | TBD | 40 | * Agenda: * Negation * harmonization across specification families * other vocab topics * Michael T to Pharmacy/BRR re medication knowledge * Meeting notes: |
Patient Care | Accepted: CIMI, Vocab, Clin Genomics, SD, OO | Jay | who? | ||
Day | Time | Room | # | Event | Host | Joining | Chair | Scribe | |
Wednesday Jan 31 |
AM | Q1 | TBD | 20 | * Agenda: FHIR Change requests - Joint with OO to discuss Procedure/ProcedureRequest * Meeting notes |
Patient Care | Accepted: OO | Michelle | Emma |
Q2 | TBD | NA | * Agenda: PA hosted joint meeting -- Episode of Care; Care Team * Meeting notes: |
PA | Accepted: PC | NA | Michelle / Stephen | ||
PM | lunch | TBD |
20 | * Agenda: Clinician-On-FHIR Preperation meeting * Meeting notes |
Patient Care | Russ | Emma | ||
Q3 | TBD | NA | * Agenda: FHIR topics - Blood Transfusion * Meeting notes: |
OO | Accepted: PC Invited: CQI, CDS, Pharmacy, OO, PA, FHIR-I |
NA | Who? | ||
Q3b | TBD | NA | * Agenda: Common Clinical Registry Framework * Meeting notes: |
CIC | Accepted: PC Invited: CQI |
NA | Who? | ||
Q4 | TBD | 30 | * Agenda: Allergy/Intolerance topic meeting. Drug list approach & Issues.
Allergy resource maturity * Meeting notes: |
Patient Care | Accepted: Pharmacy, Vocab | Jay | who? | ||
Day | Time | Room | # | Event | Host | Joining | Chair | Scribe | |
Thursday Feb 1 |
AM | Q1a | TBD | 35 | Care Plan -invite FHIR, Structured Docs, Pharmacy
|
Patient Care | Accepted: Pharmacy, LHS, SD | Laura | Emma |
Q1b | TDB | NA | Joint meeting with OO, CDS, PC, Templates | OO | Accepted: Patient Care | NA | Stephen | ||
Q2 | TBD | 25 | Joint meeting with SD and Templates
|
Patient Care | Accepted: SD Invited: Templates |
Stephen | Emma | ||
PM | lunch | TBD |
10 | Co-Chair Admin Meeting | Patient Care | Michelle | Michelle | ||
Q3a | TBD | 20 | *Agenda: FHIR Change Requests related to AdverseEvent Meeting notes: |
Patient Care | Accepted: BRR, FHIR-I | Michelle | Michelle | ||
Q3b | TBD | NA | Joint meeting with CS, OO, and PC. * Meeting notes |
CS | Accepted: Patient Care | NA | Stephen | ||
Q4 | TBD | NA | * Agenda: LHS - CareTeam DAM * ONC/CMS eLTSS Project * Meeting notes |
LHS | Patient Care | NA | Stephen, Emma, Laura? | ||
Day | Time | Room | Event | Host | Joining | Chair | Scribe | ||
Friday Feb 2 |
AM | Q1 | ClinFHIR | ||||||
Q2 | ClinFHIR | ||||||||
PM | Q3 | ClinFHIR | |||||||
Q4 | No meeting |
Meetings
Monday Q2
Questions
- Does PC specify value sets, or only semantics of value sets?
- Is PC responsible for maintenance and harmonization of value sets?
- Can PC suggest FHIR use SD values, or vice versa?
- Should FHIR data type policy trump interoperability?
- Does legacy momentum count? I.e., should C-CDA have more weight than FHIR?
- Or realm? I.e., should FHIR have more weight than C-CDA?
- Should PC simply specify values in the DAM and expect SD & FHIR to conform?
- Or maintain concept maps for divergent value sets?
- Who should be in the discussion
- Patient Care
- Vocabulary
- Structured Documents
- FHIR
- Technical Steering Committee
- Architectural Review Board